Usana Health Sciences (USNA) Total Liabilities (2010 - 2026)

Usana Health Sciences (USNA) has reported Total Liabilities for 17 consecutive years, with $132.2 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Total Liabilities fell 11.23% year-over-year to $132.2 million in Q3 2026; TTM through Jul 2026 was $132.2 million, a 11.23% decrease from a year earlier, with the FY2026 full-year figure at $156.6 million, down 3.22% from the prior year.
• Total Liabilities was $132.2 million for Q3 2026 at Usana Health Sciences, down from $144.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $183.0 million in Q2 2022 and troughed at $119.2 million in Q2 2024.
• A 5-year average of $148.2 million and a median of $145.0 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities declined 19.4% in 2022 and advanced 25.86% in 2025, its largest moves.
• Over 5 years, Total Liabilities stood at $162.1 million in 2022, then dropped by 16.36% to $135.6 million in 2023, then rose by 19.41% to $161.9 million in 2024, then dropped by 10.39% to $145.0 million in 2025, then decreased by 8.83% to $132.2 million in 2026.
• The last three Total Liabilities figures came in at $132.2 million (Q3 2026), $144.2 million (Q2 2026), and $156.6 million (Q1 2026), per Business Quant data.